Replies to post #41176 on Intellicell Biosciences Inc (fka SVFC)

[ImOnABoat]

Without some sort of a miracle happening -- if that's your thing -- $1 is not even close to realistic. But it sure as hell should trade at a couple pennies a share even right now, without any further developments.

[cazual]

International Patent for SVFC Technology pending and potential for globalization of technology, US Patent granted....intellicell labs in hospitals and ambulatory surgical centers....potential for billion dollar company...yes a $1.00+++target is possible:)

Can not discuss other stocks on the SVFC message board but there have been a number of emerging biotech's that have started as OTC and up listed into nasdaq and amex:)

GO SVFC $$$$

[sim2010]

You can see these kind of claims in all the penny stocks. These are mere speculations and may or may not be possible depending on the company's performance and unforeseen circumstances. The realistic pps expectations are 1-10 cents in the near future.

[Mad Money Monkey]

Possibly Parabolic? Yes (Depends on your view of "Parabolic"). Realistic near term IMO: .10-.50 More? Dunno. Look at VRM*. Went from .01 to $34+, but their SS was MUCH, MUCH better. And keep in mind, Bio-Techs can go Parabolic. BUT REMEMBER, WE ARE IN SUB-PENNY's AND CURRENTLY @ .0026. A total loss is possible as well. Dreaming is good, just temper them dreams with common sense. I recently learned the hard way. LITTERALLY (-$$$). JMO.

[gempicker]

You have to look at it in terms of market value or market cap. They raised the AS for a reason and one must reasonably assume the OS goes to about 1 billion to stabilize debt and finance forward. With that said, 2-3 cents only puts this to a market cap it was at earlier this year before the legal shenanigans and shark feeding.

They are close to patent approvals and have had additional clinical success. More clinicals underway, super advisory team and new partnerships in the stem cell space seem highly likely. Leading technology in this field can easily balloon this market value to a few hundred million this year, or 10-20 cents. From there it all depends on share structure, revenue build out, clinical successes, etc. Can this be a billion dollar company? Sure, just may take several years and some good luck. Although, I would not be surprised to see buyout offers at some point roll in prior to this company even getting close to maturity.